During the past decade, Northwell Health System conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwell Health System" #1 sponsor was "Aimmune Therapeutics, Inc." with 3 trials, followed by "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Icahn School of Medicine at Mount Sinai" with 1 trials sponsored, "Medtronic Cardiovascular" with 1 trials sponsored and "Société des Produits Nestlé (SPN)" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwell Health System" #1 collaborator was "Medtronic" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Vanderbilt University Medical Center" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Northwell Health System" are "Peanut Allergy" (3 trials), "Atrial Fibrillation" (1 trials), "Bleeding" (1 trials), "Cow Milk Allergy" (1 trials) and "Locally Advanced Rectal Cancer" (1 trials). Many other conditions were trialed in "Northwell Health System" in a lesser frequency.

Most popular intervention types in "Northwell Health System" are "Biological" (3 trials), "Drug" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "AR101" (3 trials), "Antiplatelet-only strategy" (1 trials), "Capecitabine" (1 trials), "Control extensively hydrolyzed formula" (1 trials) and "Oral Anticoagulant plus background antiplatelet therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwell Health System" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Northwell Health System". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Northwell Health System, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northwell Health System, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".